Field Medical Reports 12-Month Field PULSE Trial Results
Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...
electrophysiology
Advertisement
Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia
LAGUNA HILLS, Calif. — September 16, 2026 Adagio Medical Holdings, Inc. announced the first patient enrollment in its FDA-approved...
IceCure Medical Expands ChoICE Study for Breast Cancer
Caesarea, Israel, August 7, 2026 IceCure Medical has announced a significant expansion of its U.S. post-marketing clinical program with...
Ractigen Advances Phase II Trial of RAG-17 for SOD1-ALS
Nantong, China, August 7, 2026 Ractigen Therapeutics has announced a significant milestone in the development of its investigational RNA...
Reckitt Secures FDA Approval for New Mucinex 12HR Therapy
Nutley, New Jersey, USA, August 5, 2026 Reckitt has received U.S. Food and Drug Administration (FDA) approval for Mucinex®...
Advertisements
Medtronic Expands CE Mark for Sphere-9 in Ventricular Ablation
Galway, Ireland, August 6, 2026 Medtronic has secured an expanded CE Mark indication for its Affera™ Mapping and Ablation...
Stereotaxis Launches Hungary’s First Robotic Cardiology Program
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
Stereotaxis Completes Robocath Acquisition to Expand Surgical Robotics Portfolio
ST. LOUIS and ROUEN, France, July 9, 2026 Stereotaxis announced the successful completion of its previously announced acquisition of...
Johnson & Johnson Wins FDA Approval for Dual Energy Platform
IRVINE, Calif., July 8, 2026 Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA)...
Advertisement
